Group items tagged

The worldwide Glaucoma Drugs Market is conscientiously looked into inside the report while generally focusing on top players and their business strategies, topographical development, advertise sections, serious scene, assembling, and evaluating and value structures. Each area of the examination study is extraordinarily arranged to investigate key parts of the overall Glaucoma Drugs Market. for instance…

AngioDynamics has received approval from the US Food and Drug Administration (FDA) for an investigational device exemption (IDE) application of its NanoKnife System in the treatment of stage III pancreatic cancer.

Avanos Medical has secured US Food and Drug Administration (FDA) 501(k) clearance for its postoperative pain management device ON-Q Bolus.

The US Food and Drug Administration (FDA) has rejected Helius Medical Technologies' premarket submission for the Portable Neuromodulation Stimulator (PoNS) device due to a lack of data.

Biotronik has secured approval from the US Food and Drug Administration (FDA) for the use of its Acticor and Rivacor cardiac rhythm management (CRM) devices to treat heart arrhythmias.

Steen Solution Perfusate to heSwedish medical technology firm Xvivo Perfusion has received the US Food and Drug Administration (FDA) approval for the use of its Xvivo Perfusion System with lp in lung transplant procedure.

The US Food and Drug Administration (FDA) has approved the new Cochlear Nucleus Profile Plus Series Cochlear Implant and the Nucleus 7 Sound Processor's new built-in connectivity.

Scientists based at EPFL's Institute of Bioengineering in Lausanne, Switzerland have simulated aspects of embryo formation inside a microfluidic chip, setting the stage for fabricating functional tissues and organs for drug testing and transplantation.

The US Food and Drug Administration (FDA) has issued a statement warning healthcare providers about potential complications in patients fitted with both programmable cerebrospinal fluid (CSF) shunt systems and certain magnetic hearing devices.

Compliance and enforcement actions by the US Food and Drug Administration (FDA) have dramatically declined under the Trump administration, with medical devices seeing the steepest drop, according to a new report.

The US Food and Drug Administration (FDA) has labelled a recall of circular staplers by Johnson & Johnson (J&J) unit Ethicon as Class I, or high risk.

Material sciences company W. L. Gore & Associates has received approval from the US Food and Drug Administration (FDA) for its Tag Conformable Thoracic Stent Graft, a thoracic endovascular aortic repair (TEVAR) device.

ImmunoGen has presented full data from the Phase III Forward I study of mirvetuximab soravtansine in ovarian cancer at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, saying that it failed to meet the primary endpoint of progression-free survival (PFS).